Your browser doesn't support javascript.
loading
SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine.
Giménez, Estela; Albert, Eliseo; Burgos, Javier S; Peiró, Salvador; Salas, Dolores; Vanaclocha, Hermelinda; Limón, Ramón; Alcaraz, María Jesús; Sánchez-Payá, José; Díez-Domingo, Javier; Comas, Iñaki; Gonzáles-Candelas, Fernando.
Afiliação
  • Giménez E; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Albert E; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Burgos JS; General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain.
  • Peiró S; Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain.
  • Salas D; Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain; General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain.
  • Vanaclocha H; General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain.
  • Limón R; General Directorate of Healthcare. Department of Health, Valencian Government, Valencia, Spain.
  • Alcaraz MJ; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Sánchez-Payá J; Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain; Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • Díez-Domingo J; Foundation for the promotion of health and biomedical research of the Valencian Community (FISABIO), Valencia, Spain.
  • Comas I; Biomedicine Institute of Valencia, Spanish Research Council (CSIC).
  • Gonzáles-Candelas F; CIBER in Epidemiology and Public Health, Spain, Joint Research Unit "Infection and Public Health" FISABIO-University of Valencia, Valencia, Spain; Institute for Integrative Systems Biology (I2SysBio), CSIC-University of Valencia, Valencia, Spain.
J Infect ; 84(6): 834-872, 2022 06.
Article em En | MEDLINE | ID: mdl-35245583
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article